FY2025 · period end Dec '25 · from the 10-K filed Mar 25, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B | negative: -$0.00B | negative: -$0.00B | $0.00B |
| Operating Income | — | — | — | — | — |
| Net Income | negative: -$0.01B | negative: -$0.01B | negative: -$0.01B | negative: -$0.01B | negative: -$0.00B |
| EPS (Diluted) | negative: -$1.90 | negative: -$5.19 | negative: -$10.87 | negative: -$0.87 | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Total Liabilities | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stockholders' Equity | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Cash & Equivalents | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | negative: -$0.01B | negative: -$0.01B | negative: -$0.01B | negative: -$0.00B | negative: -$0.00B |
| Capital Expenditures | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Free Cash Flow | negative: -$0.01B | negative: -$0.01B | negative: -$0.01B | negative: -$0.00B | negative: -$0.00B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 21.3% | 13.1% | negative: -10.4% | negative: -8.5% | 21.5% |
| Operating Margin | negative: -3.2% | negative: -4.8% | negative: -5.8% | negative: -8.3% | negative: -4.5% |
| Net Margin | negative: -2.9% | negative: -4.7% | negative: -5.8% | negative: -8.6% | negative: -4.7% |
| Return on Equity | negative: -83.6% | negative: -106.0% | negative: -139.1% | negative: -268.5% | negative: -1563.5% |
| Return on Assets | negative: -76.0% | negative: -96.7% | negative: -122.2% | negative: -206.1% | negative: -393.6% |
| Debt / Equity | — | — | — | — | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001829126-26-007468 | Jul 8, 2026 | Jul 9, 2026 | Jul 9, 2026 20:30 UTC | EDGAR |
| 10-Q | 0001829126-26-005226 | Mar 31, 2026 | May 14, 2026 | May 14, 2026 20:00 UTC | EDGAR |
| 10-K | 0001829126-26-002695 | Dec 31, 2025 | Mar 25, 2026 | Mar 25, 2026 20:05 UTC | EDGAR |
| 8-K | 0001829126-26-000089 | Jan 7, 2026 | Jan 7, 2026 | Jan 7, 2026 21:35 UTC | EDGAR |
| 10-Q | 0001829126-25-009128 | Sep 30, 2025 | Nov 13, 2025 | Nov 13, 2025 21:06 UTC | EDGAR |
| 8-K | 0001829126-25-008926 | Nov 4, 2025 | Nov 7, 2025 | Nov 7, 2025 21:05 UTC | EDGAR |
| 8-K | 0001829126-25-008525 | Oct 24, 2025 | Oct 29, 2025 | Oct 29, 2025 20:05 UTC | EDGAR |
| 8-K | 0001829126-25-008181 | Oct 10, 2025 | Oct 16, 2025 | Oct 16, 2025 20:30 UTC | EDGAR |
Direct links to SEC EDGAR. LUCY has additional filings available on the SEC site.
6 numbers Innovative Eyewear Inc later changed — same XBRL tag, both filings linked.
Net Cash Provided by (Used in) Operating Activities·Q2 2023
Notable restatementwas-$3.3M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Operating Activities·Q3 2022
Notable restatementwas-$2M
Revised down in a 10-Q.
Net Cash Provided by (Used in) Operating Activities·Q1 2023
Notable restatementwas-$1.4M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Operating Activities·Q3 2023
Notable restatementwas-$4.6M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Financing Activities·Q1 2023
Notable restatementwas$1.4M
Revised down in a 10-Q.
Net Cash Provided by (Used in) Financing Activities·Q3 2023
Notable restatementwas$7.2M
Revised down in a 10-Q.
LUCY is not the only one.
See every restatement we've found across the market — or get an alert the next time LUCY revises a number.
Restatements are detected by comparing every vintage of a fact across all of Innovative Eyewear Inc's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows LUCY's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Innovative Eyewear Inc — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on LUCY yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on LUCY and publish the result to your public profile.
Ask about Innovative Eyewear Inc
Continue in Workspace — cited answers on LUCY, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs